SCHEMBL600415

SCHEMBL600415

CCOC(=O)n1ccc2ccccc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.61
TSHR P16473 3/20 0.53
RAB9A P51151 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
HTR3E A5X5Y0 1/20 0.48
HTR3B O95264 1/20 0.48
CHRNB2 P17787 1/20 0.48
CHRNA7 P36544 1/20 0.48
CHRNA4 P43681 1/20 0.48
HTR3A P46098 1/20 0.48
HTR3D Q70Z44 1/20 0.48
HTR3C Q8WXA8 1/20 0.48
BCHE P06276 1/20 0.45
ALDH1A1 P00352 1/20 0.45
KMT2A Q03164 1/20 0.45
PTPN1 P18031 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
LPO P22079 4/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30109103 1.00 NOTUM (0.61) NOTUMTSHRRAB9AL3MBTL1HTR3E
Hydrochloric Acid SCHEMBL7492685 0.97 NOTUM (0.57) NOTUMTSHRRAB9AL3MBTL1HTR3E
Hydrochloric Acid SCHEMBL7492690 0.97 NOTUM (0.57) NOTUMTSHRRAB9AL3MBTL1HTR3E
SCHEMBL7169526 0.89 NOTUM (0.56) NOTUMTSHRRAB9AL3MBTL1HTR3E
SCHEMBL5635573 0.86 NOTUM (0.53) NOTUMTSHRRAB9AL3MBTL1HTR3E
SCHEMBL7167672 0.84 P2RX4 (0.50) NOTUMTSHRRAB9AL3MBTL1HTR3E
SCHEMBL30711215 0.82 NOTUM (0.65) NOTUMTSHRRAB9AL3MBTL1HTR3E
SCHEMBL1173678 0.82 NOTUM (0.65) NOTUMTSHRRAB9AL3MBTL1HTR3E
SCHEMBL7162130 0.82 L3MBTL1 (0.53) NOTUMTSHRRAB9AL3MBTL1HTR3E
SCHEMBL4176193 0.81 NOTUM (0.50) NOTUMTSHRRAB9AL3MBTL1HTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108069918-B Method for preparing 3-difluoromethyl isoxazole compound by one-pot method 江西师范大学 2021-05-28 CN claimed
CN-102786463-B Method for preparing 5-acetoxyl-3-indole carboxylic acid ethyl ester ZHEJIANG GENEBEST PHARMACEUTICAL CO LTD 2013-12-18 CN claimed
US-20130123326-A1 ALLOSTERIC BINDING COMPOUNDS REGION MIDTJYLLAND (DK) 2013-05-16 US claimed
CN-102786463-A Method for preparing 5-acetoxyl-3-indole carboxylic acid ethyl ester ZHEJIANG GENEBEST PHARMACEUTICAL CO LTD 2012-11-21 CN claimed
US-20120095048-A1 ALLOSTERIC BINDING COMPOUNDS REGION MIDT JYLLAND (DK) 2012-04-19 US claimed
EP-2398760-A1 ALLOSTERIC BINDING COMPOUNDS Aarhus Universitet (DK) 2011-12-28 EP claimed
WO-2010094289-A1 ALLOSTERIC BINDING COMPOUNDS AARHUS UNIVERSITET (DK) 2010-08-26 WO claimed
US-7632956-B2 Fragrance ingredients, applications, compositions and methods GIVAUDAN SA (CH) 2009-12-15 US claimed
US-20090036690-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2009-02-05 US claimed
EP-1799797-B1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2008-05-14 EP claimed
EP-1799797-A1 ORGANIC COMPOUNDS Givaudan SA (CH) 2007-06-27 EP claimed
WO-2006039822-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2006-04-20 WO claimed
EP-1335917-A2 CONDENSED PYRIDOINDOLE DERIVATIVES Lilly Icos LLC (US) 2003-08-20 EP claimed
WO-2002028859-A2 CONDENSED PYRIDOINDOLE DERIVATIVES LILLY ICOS LLC (US) 2002-04-11 WO claimed
CN-113181362-B Medicament for preventing and/or treating amyotrophic lateral sclerosis 国立大学法人京都大学 2023-06-13 CN disclosed
CN-108530335-B Indole compound and preparation method and application thereof 华南农业大学 2021-08-31 CN disclosed
CN-107963996-B Method for preparing 3-trifluoromethyl isoxazole compound by one-pot method 江西师范大学 2021-06-11 CN disclosed
WO-2000058286-A2 METHOD OF PRODUCING HETEROCYCLIC CARBAMATES FROM AZA-HETEROCYCLIC COMPOUNDS AND CARBON DIOXIDE Gödecke GmbH (DE) 2000-10-05 WO disclosed
EP-1001934-A1 INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 2000-05-24 EP disclosed
WO-1999005104-A1 INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036690-A1 ORGANIC COMPOUNDS TRPA1, IDO1, INMT NOTUM 68/4885TSHR 3438/4885RAB9A 4023/4885
US-20120095048-A1 ALLOSTERIC BINDING COMPOUNDS GRIN2C, GRM2, GRIN2B NOTUM 4008/4885TSHR 534/4885RAB9A 1225/4885
US-20130123326-A1 ALLOSTERIC BINDING COMPOUNDS GRIN2C, GRM2, GRIN2B NOTUM 4008/4885TSHR 534/4885RAB9A 1225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.